Get the app
US › Healthcare

Lite Strategy, Inc. (LITS)

US · Healthcare · Biotechnology

$1.15-4.17%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Net profit
$-13.0M
EPS
$-0.38

Key statistics

Market cap
$37.1M
Forward P/E
4.6
P/B
0.71
Book value
$1.62
EPS (TTM)
$-2.12
52-week high
$2.26
52-week low
$0.69
50-day MA
$1.10
200-day MA
$1.11
Beta
0.01

Shareholding

Insiders
1.38%
Institutions
19.36%

Largest institutional holders

FundStake
Renaissance Technologies Corp4.10%
Vanguard Capital Management, LLC3.36%
RLH Capital LLC2.65%
Two Sigma Investments LLC1.83%
Geode Capital Management, LLC1.20%
Citadel Advisors Llc1.18%
BlackRock Inc0.91%
Marshall Wace Asset Management Ltd0.77%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Lite Strategy, Inc. — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-19.